| Market Cap | 16.52M | P/E | - | EPS this Y | -31.60% | Ern Qtrly Grth | - |
| Income | -47.36M | Forward P/E | -1.70 | EPS next Y | 60.00% | 50D Avg Chg | -25.00% |
| Sales | 76.07M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -60.00% |
| Dividend | N/A | Price/Book | 0.30 | EPS next 5Y | - | 52W High Chg | -91.00% |
| Recommedations | 2.00 | Quick Ratio | 0.70 | Shares Outstanding | 10.68M | 52W Low Chg | 1,292.00% |
| Insider Own | 14.77% | ROA | -12.96% | Shares Float | 7.16M | Beta | 1.91 |
| Inst Own | 9.91% | ROE | -148.59% | Shares Shorted/Prior | 566.28K/106.61K | Price | 2.38 |
| Gross Margin | 23.32% | Profit Margin | -74.98% | Avg. Volume | 102,841 | Target Price | 6.00 |
| Oper. Margin | -15.67% | Earnings Date | - | Volume | 37,318 | Change | 1.28% |
Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide. It operates through three segments: House of Brands, Commercial and Wholesale, and Pharmaceuticals. The company cultivates, processes, and supplies medicinal-grade cannabis flower, and cannabis derived medical and wellness products. It also offers food and beverage, nutraceuticals, cannabis accessories and technology, personal care, and wellness; cannabidiol (CBD) derived products, such as gummies, topicals, tinctures, and vape products; cannabis consumption accessories, personal storage, and travel accessories for the vape and dry herbs. In addition, the company manufactures and distributes pharmaceutical goods and medical cannabis products to treat a variety of health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. The company sells its products under the JustCBD, Vessel, and Phatebo brands. Flora Growth Corp. was incorporated in 2019 and is based in Fort Lauderdale, Florida.
| Roth MKM | Buy | Apr 3, 24 |